Equity
€39,375 from €117,830 in 2017
Equity fell by 67% in 8 years.
BEMIPHARMA
Lifetime
19 annual accounts with figures on one time axispeak €130,053 (2020)
-not published
lowest -€53,573 (2010)
-€179▲ €385
peak €117,830 (2017)
€39,375▼ 0.5%
-not published
peak 2 FTE (2018)
-not published
Board3 names since 2020
2 directors and 1 other
Owners2 names in the annual accounts
60% and 1 other
Documentsfilings and deeds
28-05-202628 days late
2025micro format
Loss of €179
Key points
from the 2025 annual accountsLosses
-€39,154 in five years
Every financial year from 2021 to 2025 closed with a loss. 2021 was the heaviest.
Board
1 left
A director left. Latest change 22-09-2026 · 1 in office.
2025 accounts filed 28 days after the deadlineTurnover not published (micro format)
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,920 companies had the same profile as BEMIPHARMA has now. Each dot stands for 18 companies, two years later.
90.7%
were still trading
8.0%
stopped another way
1.1%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,920 companies, not a prediction for BEMIPHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director
- 60%score equity €555,456 (2025) · 2025 annual accounts of
- 40%score equity €2.0m (2025) · 2025 annual accounts of
Recent changes
Resignation: (director)
General meeting of 02-12-2025 · Gazette deed
Registered office moved within Farciennes
Transfer of shares to · Transfer of shares to · New registered office: rue Amion, 12 à 6240 FARCIENNES · General meeting of 31-12-2020 · Gazette deed
First establishment
Rue Albert 1er 22, Farciennes
Incorporation
published on 28-12-2006 · Gazette deed
Official details
Source: KBO- Status
- Active since 18-12-2006Normal situation
- Activity
- No activity registered in the KBO
- Establishment unit
- 2.158.327.0066240 Farciennes, since 05-01-2007
- Financial year end
- 30 September
- Peppol
- Not found in the Peppol Directory
Insights on BEMIPHARMA
BEMIPHARMA files the micro format. That format states no turnover. The gross margin fell from €44,842 in 2007 to -€412 in 2024.
holds 60% of the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about BEMIPHARMA
- What is the company number of BEMIPHARMA?
- The company number of BEMIPHARMA is 0885.720.658. The VAT number is the same number with BE in front: BE 0885.720.658.
- Where is BEMIPHARMA based?
- The registered office is at Rue Amion 12, 6240 Farciennes.Company details
- What is the legal form of BEMIPHARMA?
- BEMIPHARMA is a private limited company (pre-2019) (BVBA).
- When was BEMIPHARMA founded?
- BEMIPHARMA was founded on 18-12-2006.
- Is BEMIPHARMA still active?
- Yes, BEMIPHARMA is an active enterprise in the KBO register.
- How many employees does BEMIPHARMA have?
- BEMIPHARMA had an average of 0.6 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
- What is the turnover of BEMIPHARMA?
- The annual accounts for financial year 2025 state no turnover. The micro format does not require it.
- Is BEMIPHARMA profitable?
- In financial year 2025, BEMIPHARMA made a loss of €179.
- Where can I find the annual accounts of BEMIPHARMA?
- BEMIPHARMA filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of BEMIPHARMA due?
- BEMIPHARMA must file the annual accounts for financial year 2026 by 30-04-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.